Trial Profile
A Study to Evaluate the Effect of Omalizumab on Clinically Significant Asthma Exacerbations in Patients with Inadequately Controlled Severe Persistent Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 03 Dec 2015 New trial record